Kondor Pharma selected in J&J immunity challenge

December 2, 2020

Congratulations to Emergence client Kondor Pharma who was selected by Johnson & Johnson through their QuickFire Challenge on Immune-Support. Kondor will receive up to $50,000 in grant funding, one year of residency at JLABS, and the opportunity to engage with Johnson & Johnson Innovation.

Kondor Pharma is developing clinically proven, natural products with immunomodulatory properties to support immune and cognitive health and to help people with inflammation-related ailments.

Read more on JLABS.